CATALOGO DEI PRODOTTI DELLA RICERCA

MAFFICINI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.640
NA - Nord America 4.910
AS - Asia 4.130
SA - Sud America 643
AF - Africa 104
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.444
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.781
RU - Federazione Russa 2.602
SG - Singapore 1.516
CN - Cina 1.512
GB - Regno Unito 1.494
IT - Italia 728
BR - Brasile 528
HK - Hong Kong 397
DE - Germania 379
SE - Svezia 342
IE - Irlanda 300
VN - Vietnam 280
FR - Francia 268
FI - Finlandia 217
KR - Corea 101
CA - Canada 75
NL - Olanda 60
IN - India 54
AR - Argentina 47
UA - Ucraina 47
AT - Austria 40
MX - Messico 40
BE - Belgio 39
JP - Giappone 39
ID - Indonesia 37
TR - Turchia 37
ES - Italia 36
PL - Polonia 30
IQ - Iraq 28
BD - Bangladesh 26
ZA - Sudafrica 22
TG - Togo 20
BJ - Benin 16
EC - Ecuador 16
IR - Iran 16
UZ - Uzbekistan 16
MA - Marocco 14
CO - Colombia 12
VE - Venezuela 11
AU - Australia 10
CL - Cile 10
PK - Pakistan 10
KG - Kirghizistan 9
LT - Lituania 9
NO - Norvegia 9
LV - Lettonia 8
PY - Paraguay 8
KE - Kenya 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
IL - Israele 6
PE - Perù 6
SA - Arabia Saudita 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
SK - Slovacchia (Repubblica Slovacca) 5
AL - Albania 4
AZ - Azerbaigian 4
EG - Egitto 4
NZ - Nuova Zelanda 4
UY - Uruguay 4
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
KZ - Kazakistan 3
LK - Sri Lanka 3
MY - Malesia 3
NI - Nicaragua 3
TW - Taiwan 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GA - Gabon 2
IS - Islanda 2
JM - Giamaica 2
NP - Nepal 2
PH - Filippine 2
PT - Portogallo 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CM - Camerun 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
KH - Cambogia 1
KW - Kuwait 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
Totale 16.438
Salva come PNG Salva come JPEG
Città #
Southend 1.322
Moscow 891
Singapore 716
Dallas 685
Chandler 664
Ashburn 425
Hong Kong 394
Woodbridge 316
Verona 296
Dublin 280
Beijing 272
Ann Arbor 259
Jacksonville 241
New York 188
Munich 127
The Dalles 124
Jinan 101
Los Angeles 100
Shenyang 98
Lawrence 87
Princeton 87
Houston 83
Ho Chi Minh City 81
Nanjing 76
Wilmington 75
Hebei 57
Helsinki 56
São Paulo 56
Tianjin 53
Turku 53
Redondo Beach 50
Hanoi 48
Zhengzhou 46
Santa Clara 44
Changsha 42
Columbus 42
Redmond 42
Haikou 41
London 40
Brussels 39
Ningbo 38
Hangzhou 36
Buffalo 34
Nanchang 34
Sindelfingen 34
Taizhou 34
Dong Ket 32
Guangzhou 32
Seoul 31
Seattle 29
Shanghai 28
Jiaxing 27
Lancaster 27
Vienna 27
Montreal 26
Tokyo 26
Brescia 25
Warsaw 23
Jakarta 22
Council Bluffs 21
Milan 21
Taiyuan 21
Lanzhou 20
Lomé 20
Nuremberg 20
Rome 20
Stockholm 20
Frankfurt am Main 19
San Francisco 19
Toronto 19
Brooklyn 18
Dearborn 18
Johannesburg 18
Kent 18
Belo Horizonte 17
Boardman 17
Lappeenranta 17
Mexico City 17
Poplar 17
Chennai 16
Cotonou 16
Tashkent 16
Amsterdam 15
Bologna 15
Haiphong 15
Norwalk 15
Orem 15
Redwood City 15
Rio de Janeiro 15
Chicago 14
Denver 14
Madrid 14
Falkenstein 13
Phoenix 13
Washington 13
Baghdad 12
Curitiba 12
Falls Church 12
Da Nang 11
Ankara 10
Totale 9.930
Salva come PNG Salva come JPEG
Nome #
Development of FT-IR microspectroscopy for pre-clinical and clinical applications 319
Whole-genome landscape of pancreatic neuroendocrine tumours 252
Characterization of new monoclonal antibodies specific for the extracellular domain of PTPRG, a candidate tumour suppressor gene 247
DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples 237
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 234
Genomic characterization of hepatoid tumors: context matters 232
Nuovi approcci proteomici per l'identificazione di potenziali marcatori di neoplasie pancreatiche 229
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 229
BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing 215
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel 212
Ampulla of Vater Carcinoma: Sequencing Analysis Identifies TP53 Status as a Novel Independent Prognostic Factor and Potentially Actionable ERBB, PI3K, and WNT Pathways Gene Mutations 212
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers 210
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 205
MONOCLONAL ANTIBODY FOR DIAGNOSING CHRONIC MYELOID LEUKEMIA 204
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 203
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 200
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 198
Expression of transmembrane protein tyrosine phosphatase gamma (Ptpgamma) in normal and neoplastic human tissues. 197
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 195
Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas 190
Immunohistochemical detection of arginine methylated proteins (MeRP) in archival tissues 184
High-throughput mutation profiling improves diagnostic stratification of sporadic medullary thyroid carcinomas. 184
Urokinase Plasminogen Activator Receptor Could Be a New UsefulMarker in Pancreatic Cancer and Appears to Be Related to Survival 183
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 179
CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications 178
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 178
PD-1, PD-L1 and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 176
Reporting tumor molecular heterogeneity in histopathological diagnosis 176
Impact of polymorphism of Multidrug Resistance-associated Protein 1 (ABCC1) gene on the severity of cystic fibrosis. 173
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 172
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 171
Identification of proteins released by pancreatic cancer cells by multidimensional protein identification technology: a strategy for identification of novel cancer markers 170
PTPRG Expression Correlates with Tolerogenic Phenotype in Dendritic Cells Derived from Pancreatic Cancer Patients 169
Protein Tyrosine Phosphatase Gamma (PTPgamma) is a Novel Leukocyte Marker Highly Expressed by CD34 Precursors 169
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation 168
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 166
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas 165
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 163
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes 163
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 161
Both HIV- and EIAV-based lentiviral vectors mediate gene delivery to pancreatic cancer cells and human pancreatic primary patient xenografts. 159
Specific expression patterns of epithelial to mesenchymal transition factors in gestational molar disease 158
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 158
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 158
Comparative Lesions Analysis Through a Targeted Sequencing Approach 157
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 156
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 155
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 153
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 152
Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium 150
Splice variants as novel targets in pancreatic ductal adenocarcinoma 150
Fhit down-regulation is an early event in pancreatic carcinogenesis 149
Pancreatic cancer genomics 149
Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer 146
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 145
In situ analysis of methylarginine 144
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages 143
Next-Generation Histopathologic Diagnosis: A Lesson From a Hepatic Carcinosarcoma 143
FrequentNRG1fusions in Caucasian pulmonary mucinous adenocarcinoma predicted by Phospho-ErbB3 expression 143
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 142
Perineural Invasion is a Strong Prognostic Moderator in Ampulla of Vater Carcinoma: A Meta-analysis 142
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 140
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 140
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 134
Author Correction: The landscape of viral associations in human cancers 132
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 131
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 130
ICAT is a novel Ptf1a interactor that regulates pancreatic acinar differentiation and displays altered expression in tumours. 129
Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients 126
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 126
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 125
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 124
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 124
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 122
Impact of the polymorphic variant 5 FR/G-260C in the Multidrug Resistance-associate Protein-1 gene on severity of cystic fibrosis 121
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 121
Case report: Male genital system, soft tissue and myocardial metastases in a patient with exon 11-mutated GIST of unknown origin 121
IMPACT OF POLYMORPHIC-794 CATT REPEATS OF MACROPHAGE MIGRATION INHIBITORY FACTOR PROMOTER ON SEVERITY OF CF 118
Genomic landscape of pancreatic neuroendocrine tumours: The International Cancer Genome Consortium 118
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling 113
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 109
pRB immunostaining in the differential diagnosis between pleomorphic xanthoastrocytoma and glioblastoma with giant cells 107
Receptor type tyrosine phosphatase gamma (PTP gamma) is a novel dendritic cell marker 107
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterization 104
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer 104
Comprehensive molecular characterization of mitochondrial genomes in human cancers 101
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 101
New genomic landscapes and therapeutic targets for biliary tract cancers 97
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 97
Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities 97
Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples 96
Recurrent oligodendroglioma with changed 1p/19q status 95
Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy 94
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 93
Cerebellar mass in a 31-year-old woman 92
Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study 92
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 87
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature 85
The landscape of viral associations in human cancers 82
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 82
Totale 15.337
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.054
article - articoli 47.529
book - libri 0
conference - conferenze 6.121
curatela - curatele 0
other - altro 451
patent - brevetti 500
selected - selezionate 0
volume - volumi 453
Totale 110.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021281 0 0 0 0 0 49 15 30 36 22 64 65
2021/20221.067 93 329 54 75 59 24 33 66 33 29 77 195
2022/20231.800 115 233 143 297 157 445 14 126 202 11 30 27
2023/20241.117 48 71 72 101 117 223 46 119 16 73 184 47
2024/20253.090 127 142 173 473 185 143 201 153 399 184 343 567
2025/20265.899 572 484 709 1.425 2.219 490 0 0 0 0 0 0
Totale 16.681